as a monomer. Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6319-6328. \[[PMC free article: PMC6442593](/pmc/articles/PMC6442593/)\] \[[PubMed: 30850549](https://pubmed.ncbi.nlm.nih.gov/30850549)\] 3. Arora R, Nimonkar AV, Baird D, Wang C, Chiu CH, Horton PA, Hanrahan S, Cubbon R, Weldon S, Tschantz WR, Mueller S, Brunner R, Lehr P, Meier P, Ottl J, Voznesensky A, Pandey P, Smith TM, Stojanovic A, Flyer A, Benson TE, Romanowski MJ, Trauger JW. Structure of lipoprotein lipase in complex with GPIHBP1. Proc Natl Acad Sci U S A. 2019 May 21;116(21):10360-10365. \[[PMC free article: PMC6534989](/pmc/articles/PMC6534989/)\] \[[PubMed: 31072929](https://pubmed.ncbi.nlm.nih.gov/31072929)\] 4. Gunn KH, Roberts BS, Wang F, Strauss JD, Borgnia MJ, Egelman EH, Neher SB. The structure of helical lipoprotein lipase reveals an unexpected twist in lipase storage. Proc Natl Acad Sci U S A. 2020 May 12;117(19):10254-10264. \[[PMC free article: PMC7229681](/pmc/articles/PMC7229681/)\] \[[PubMed: 32332168](https://pubmed.ncbi.nlm.nih.gov/32332168)\] 5. Falko JM. Familial Chylomicronemia Syndrome: A Clinical Guide For Endocrinologists. Endocr Pract. 2018 Aug;24(8):756-763. \[[PubMed: 30183397](https://pubmed.ncbi.nlm.nih.gov/30183397)\] 6. Blom DJ, O'Dea L, Digenio A, Alexander VJ, Karwatowska-Prokopczuk E, Williams KR, Hemphill L, Muñiz-Grijalvo O, Santos RD, Baum S, Witztum JL. Characterizing familial chylomicronemia syndrome: Baseline data of the APPROACH study. J Clin Lipidol. 2018 Sep-Oct;12(5):1234-1243.e5. \[[PubMed: 30318066](https://pubmed.ncbi.nlm.nih.gov/30318066)\] 7. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007 Apr 10;176(8):1113-20. \[[PMC free article: PMC1839776](/pmc/articles/PMC1839776/)\] \[[PubMed: 17420495](https://pubmed.ncbi.nlm.nih.gov/17420495)\] 8. Blackett P, Tryggestad J, Krishnan S, Li S, Xu W, Alaupovic P, Quiroga C, Copeland K. Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat. J Clin Lipidol. 2013 Mar-Apr;7(2):132-9. \[[PubMed: 23415432](https://pubmed.ncbi.nlm.nih.gov/23415432)\] 9. Okopień B, Bułdak Ł, Bołdys A. Benefits and risks of the treatment with fibrates--a comprehensive summary. Expert Rev Clin Pharmacol. 2018 Nov;11(11):1099-1112. \[[PubMed: 30328735](https://pubmed.ncbi.nlm.nih.gov/30328735)\] 10. Kobayashi J, Mabuchi H. Lipoprotein lipase and atherosclerosis. Ann Clin Biochem. 2015 Nov;52(Pt 6):632-7. \[[PubMed: 25995285](https://pubmed.ncbi.nlm.nih.gov/25995285)\] **Disclosure:** Yasaman Pirahanchi declares no relevant financial relationships with ineligible companies. **Disclosure:** McDamian Anoruo declares no relevant financial relationships with ineligible companies. **Disclosure:** Sandeep Sharma declares no relevant financial relationships with ineligible companies.